Glenmede Investment Management, LP Novo Nordisk A S Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Glenmede Investment Management, LP holds 163,298 shares of NVO stock, worth $7.88 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
163,298
Previous 137,990
18.34%
Holding current value
$7.88 Million
Previous $9.52 Billion
99.9%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,692Shares Held
309MCall Options Held
15.4MPut Options Held
23.9M-
Capital International Investors Los Angeles, CA17.7MShares$855 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$780 Million1.1% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$710 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$689 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$675 Million0.21% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...